Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Rainier Acquisition Corporation closes its Initial Public Offering, raising $75,000,000. The offering was managed by Chardan.
PRIVATEAug 28, 2026•about 3 hours ago
Amount Raised
$75 Million
Round Type
Post-IPO Equity
New YorkBiotechnologyHealth Care
Description
Rainier Acquisition Corporation has successfully closed its initial public offering, generating gross proceeds of $75,000,000. The offering consisted of 7,500,000 units priced at $10.00 each. The units began trading on the Nasdaq Capital Market under the ticker symbol 'RNAQU'. Chardan served as the sole book-running manager for the offering.
Company Information
Company
Rainier Acquisition Corporation
Location
New York, New York, United States
About
Rainier Acquisition Corporation is a special purpose acquisition company focused on effecting business combinations in the global life sciences industries. The Company aims to identify opportunities in therapeutics, diagnostics, genomics, and related sectors. It is led by a seasoned management team with experience in finance and healthcare. Rainier Acquisition Corporation seeks to merge with or acquire one or more businesses to create value for its shareholders.
Don't miss Rainier Acquisition Corporation's next move
Get an email the moment Rainier Acquisition Corporation raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Rainier Acquisition Corporation's next move
New YorkBiotechnologyHealth Care